Evidence map›Paper›PMID 42652113›Full record

ReviewBiomedicines2026

The Role of Endothelial-Mesenchymal Transition (EndMT) in Aneurysm Formation.

Christoph Lange, Elena Kaschina

Abstract readReview
In one paragraph

Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christoph LangeClinic for Anesthesiology and Intensive Care Medicine, Universitätsklinikum Brandenburg an der Havel, Hochstrasse 29, 14770 Brandenburg, Germany.
Elena KaschinaInstitute of Pharmacology, Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Charité-Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-8966-5070

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aneurysms represent a life-threatening disease due to their risk of rupture. Recent research points towards a role of endothelial-mesenchymal transition (EndMT) in their pathophysiology. EndMT acts as a cellular program during which endothelial cells undergo phenotypic and functional transformation into cells with mesenchymal properties. EndMT is implicated in embryogenesis, tissue repair, remodeling, angiogenesis and fibrosis. The studies performed in the last decade have gained new insights in the cell signaling pathways during aneurysm development in the context of EndMT and suggested new drug targets to prevent aneurysmal growth. This review summarizes the current knowledge on EndMT in various forms of aneurysm, such as abdominal and thoracic aortic aneurysms, intracranial aneurysms and coronary artery aneurysm due to Kawasaki disease.

Indexed as

aneurysmendothelial cellsendothelial–mesenchymal transition (EndMT)

Identifiers

PMID42652113
PMCPMC13509576

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.